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WHAT THIS PAPER ADDS
 Cerebral hyperperfusion syndrome (CHS) after carotid endarterectomy (CEA) is potentially life threatening and therefore identi-
ﬁcation of patients at risk is essential. Intra-operative transcranial Doppler (TCD) monitoring is associated with both false positive
and false negative results. In the present study we assessed the predictive values of an additional TCD measurement in the early
postoperative phase. We found that postoperative TCD signiﬁcantly increased both the positive and negative predictive values. Our
adjusted monitoring strategy using perioperative TCD may contribute to the further reduction of adverse events after carotid
revascularisation.a r t i c l e i n f o
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Objectives: To determine the diagnostic value for predicting cerebral hyperperfusion syndrome (CHS) by
adding a transcranial Doppler (TCD) measurement in the early postoperative phase after carotid
endarterectomy (CEA).
Design: Patients who underwent carotid endarterectomy between January 2004 and August 2010 and in
whom both intra- and postoperative TCD monitoring were performed were included.
Methods: In 184 CEA patients the mean velocity (Vmean) preoperatively (V1), pre-clamping (V2), post-
declamping (V3) and postoperatively (V4) was measured using TCD. The intra-operative Vmean increase
((V3  V2)/V2) was compared to the postoperative increase ((V4  V1)/V1) in relation to CHS. CHS was
diagnosed if the patient developed neurological complaints in the presence of a preoperative Vmean
increase >100%.
Results: Sixteen patients (9%) had an intra-operative Vmean increase >100% and 22 patients (12%)
a postoperative Vmean increase of >100%. In 10 patients (5%) CHS was diagnosed; two of those had an
intra-operative Vmean increase of >100% and nine postoperative Vmean increase >100%. This results in
a positive predictive value of 13% for the intra-operative and 41% for the postoperative measurement.
Conclusions: Besides the commonly used intra-operative TCD monitoring additional TCD measurement in
the early postoperative phase is useful to more accurately predict CHS after CEA.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.þ31 88 7555017.
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ciety for Vascular Surgery. PublisheCarotid endarterectomy (CEA) is the standard treatment for
patients with high-grade symptomatic stenosis of the internal
carotid artery (ICA). Operative treatment has also been demon-
strated to be superior to medical treatment in patients younger
than 75 years with an asymptomatic high-grade stenosis of the ICA.d by Elsevier Ltd. All rights reserved.
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serious procedure-related complications resulting in perioperative
death or stroke in up to 5% of patients.1,2
Perioperative strokes can be categorised by time of onset.
Ischaemic strokes that occur during the operation and become
apparent upon recovery from anaesthesia are thought to be caused
by hypoperfusion during clamping or by thrombo-embolism.3 Post-
operative strokes develop after a symptom-free interval and are
mainly caused by local thrombosis, thrombo-embolism or cerebral
hyperperfusion syndrome (CHS).3 Introduction of intra-operative
cerebral monitoring using computerised electroencephalography
(EEG) and transcranial Doppler (TCD) has signiﬁcantly decreased the
intra-operative stroke rate.4e6 However, complications in the post-
operative phase cannot be prevented by this approach.7
CHS can occur during the ﬁrst few days up to 4 weeks after CEA
in 1e3% of patients.8 It is hypothesised that in a previously hypo-
perfused area with a disturbed autoregulation a sudden increase of
blood ﬂow may lead to cerebral hyperperfusion.9 CHS can cause
a spectrum of symptoms including headache, vomiting, neurolog-
ical deﬁcit or seizures.10 Patients may have only mild and transient
symptoms, but if not recognised and treated adequately in time
(i.e., strict blood pressure control), haemorrhagic stroke and
subsequent death may occur in up to 40% of patients.11
The generally accepted deﬁnition of postoperative cerebral
hyperperfusion in the context of CEA is deﬁned as an increase in
cerebral blood ﬂow (CBF) of >100% over baseline.12 This occurs in
approximately 10% of CEA patients13 and has been associated with
a 10-fold higher risk for postoperative intra-cerebral haemorrhage in
patients operated under general anaesthesia.12,14 Changes in CBF are
correlated with changes in the mean blood velocity (Vmean) in the
ipsilateral middle cerebral artery (MCA) as measured with TCD.15,16
Currently, during CEA under general anaesthesia, an increase in
Vmean of>100%3minafter declamping the ICA, compared to the pre-
clamping Vmean is the most commonly used predictor of CHS.11,17e19
However, intra-operative TCD monitoring is associated with both
false negative and false positive results.11,20 Therefore, amore precise
method is needed to predict which patients are at risk for CHS.
This study aimed to assess the predictive power of intra-
operative TCD monitoring regarding the development of CHS, by
introducing an additional TCD measurement in the ﬁrst two post-
operative hours.
Materials and Methods
Patients
Data were derived from two Dutch Vascular referral centres.
Patients operated between February 2009 and August 2010 in the
University Medical Center Utrecht (UMCU) were prospectively and
patients who underwent CEA between January 2004 and August
2010 in St. Antonius Hospital, Nieuwegein, were retrospectively
included. All patients who underwent CEA for a high degree ICA
stenosis and in whom both intra- and postoperative TCD moni-
toring were performed were included.
Carotid endarterectomy
In both centres, surgery was performed under general anaes-
thesia and all patients received the same anaesthetic regimen.
Anaesthesia was induced with propofol, sufentanil and rocuro-
nium, and maintained with isoﬂurane. After tracheal intubation,
mechanical ventilationwas adjusted tomaintain normocapnia. CEA
was performed by an experienced vascular surgeon or by a vascular
trainee under supervision in a standardised way. An intra-luminal
shunt was used selectively in case of EEG asymmetry ora decrease of >60% of Vmean measured by TCD.21 Postoperatively,
patients stayed for at least 6 h on the recovery ward for continuous
blood pressure (BP) monitoring.
Deﬁnition of study end points
CHS (primary end point) was diagnosed if the patient developed
headache, confusion, seizures, intracranial haemorrhage or focal
neurological deﬁcits in the presence of postoperative cerebral
hyperperfusion (deﬁned as >100% increase of the preoperative
Vmean) after a symptom-free interval. The diagnosis of CHS was
made by an independent neurologist.8
Postoperative hypertension (PH) (secondary end point) was
deﬁned either as an absolute high BP threshold (BP >160 mmHg
systolic) or as a relative high BP (20% above the preoperative BP).22
Moreover, PH was also scored if, in patients identiﬁed as being at
risk for CHS based on the intra-operative Vmean increase, BP was
raised above the adjusted restriction (see below).22
Measurements
The preoperative BP was measured (non-invasively) during the
preoperative TCD measurement. If these data were not available,
the BP obtained during preoperative assessment was used.
In the perioperative period, BP was measured using an intra-
arterial catheter in the radial or brachial artery. Systolic BP was
kept above 140 mmHg during cross-clamping.
For the TCD registration, a pulsed Doppler transducer (Pioneer
TC4040, EME, Überlingen, Germany), gated at a focal depth of
45e60 mm, was placed over the temporal bone to insonate the
main stem of the ipsilateral MCA, with the TCD transducer being
ﬁxed with a head frame and Vmean was recorded continuously. The
values used for further analysis were gathered in real time on
indicated data points as described below.
Post-CEA anti-hypertensive treatment protocol
All patients with PH, that is, BP >160 mmHg systolic (absolute),
>20% above the preoperative BP, or BP risen above the individual
restriction in patients with an intra-operative Vmean increase>100%,
underwent strict individualised BP control during the early post-
operative period. Anti-hypertensive treatment consisted of intrave-
nous labetalol (ﬁrst choice) orclonidine (secondchoice). If BPwasnot
controlled appropriately after 6 h on the recovery ward, the patient
was transferred to the medium care unit (MCU) for continuous BP
monitoring and treatment until BP reached the appropriate limits. If
BP was within the required limits, intravenous anti-hypertensive
treatment was tapered as soon as possible and an oral beta-blocker
(labetalol or metoprolol) was started. If PH occurred on the nursing
ward, oral beta-blockers (labetalol or metoprolol) were given ﬁrstly.
However, if the BP was not sufﬁciently controlled or even increased,
whether or not in combination with neurological symptomatology,
(re)transfer to the MCU was established.
Timeframes
Four timeframes were indicated, which are schematically
shown in Fig. 1.
For the preoperative Vmean (V1), a TCD measurement of the MCA
ipsilateral to the treated carotid arterywas performedwithin 1week
prior to operation. During operation, the pre-clamping Vmean (V2)
was registered 30 s prior to carotid cross-clamping. The post-
declamping Vmean (V3) was determined 3 min after declamping. An
additional postoperative Vmean (V4) was measured within the ﬁrst
hour after arrival on the recovery ward. All patients received their
   V3    V2 
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Post-operative
    V4 
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Figure 1. Timeline TCD measurements around CEA. V1: Preoperative mean blood
velocity (Vmean) prior to CEA. V2: Pre-clamping Vmean measured at most 1 min before
carotid clamping. V3: Post-declamping Vmean measured 3 min after carotid declamping.
V4: Postoperative Vmean measured within the ﬁrst 2 h on the recovery warm.
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measurementwas performed in all patients in theUMCU, butmainly
in caseof hypertensionoran increasedV3 in theSt. Antoniushospital.
The intra-operative increase of Vmean was deﬁned and calculated
as follows:
ðV3  V2Þ=V2  100%:
For calculating the ‘postoperative’ increase of Vmean the
following formula was used:
ðV4  V1Þ=V1  100%:Statistical analysis
Patients were classiﬁed according to the relative increase in
Vmean (i.e., less or more than 100% increase) at predeﬁned two
timeframes (intra-operatively and postoperatively) in relation to
CHS occurrence (Fig. 1).
The positive predictive value (PPV) and negative predictive
value (NPV) of both intra-operative and postoperative increase of
Vmean were calculated. Differences in BP between the intra-
operative and postoperative measurements and between CHS and
non-CHS groups were compared using the Chi-square test forTable 1
Patient characteristics.
Patient characteristics Combined N ¼ 112
Mean (SD)
Age (yrs) 68.8 (9.9)
Number of patients (%)
Gender (male) 141 (77%)
Risk factors
Diabetes 36 (20%)
Hypertension 135 (73%)
Hypercholesterolaemia 164 (89%)
Coronary artery disease 50 (27%)
Smoking 61 (33%)
Alcohol use 124 (67%)
Site (right) 83 (45%)
Symptomatic 159 (87%)
Degree of stenosis (ipsilateral)
>70% 174 (95%)
 50% 10 (5%)
Degree of contralateral stenosis
Occlusion 27 (15%)
Stenosis >70% 17 (9%)
Stenosis 50e70% 30 (16%)
Stenosis <50% 94 (51%)
Unknown 16 (9%)
Shunt use 33 (18%)
Post-operative hypertension 34 (19%)
Cerebral hyperperfusion syndrome 10 (5%)categorical variables and Student’s t-test or ManneWhitney U test
for continuous variables, as appropriate. These statistical analyses
were performed using the Statistical Package for Social Sciences
(SPSS) 15.0 software. A conﬁdence level of less than 5% (p < 0.05)
was considered signiﬁcant.
Results
Patient characteristics
In the St. Antonius Hospital Nieuwegein 560 patients under-
went CEA during the time of the study. Of these 560, 72 (13%)
received both intra- and postoperative TCD monitoring and were
included for the present analysis. In the UMCU, a postoperative TCD
measurement was performed in 112 of 211 patients (53%) who
underwent CEA within the time frame February 2009eAugust
2010. Therefore, out of 771 patients a total of 184 patients were
included in this study (Table 1). In both hospitals, patients were
excluded for the study because of logistic reasons.
The majority of patients were symptomatic (159 patients, 87%).
Thirty-three patients (18%) required the use of an intra-luminal
shunt because of either EEG asymmetry or a decrease of >60% of
Vmean measured by TCD. After stratiﬁcation according to hospital,
the majority of patients’ characteristic parameters were compa-
rable. Three variables signiﬁcantly differed between the St. Anto-
nius and the UMCU: alcohol usage (54% vs. 76%, p ¼ 0.005,
respectively), PH (26% vs. 13%, p ¼ 0.027, respectively) and shunt
use (31% vs. 10%, p < 0.001, respectively).
TCD measurements
Sixteen patients (9%) had an intra-operative Vmean increase
>100% (Fig. 2; B). Postoperatively, a Vmean increase >100% was
found in an additional 15 patients (8%) (Fig. 2; D and F). In seven
patients (4%) both the intra-operative and the postoperative
measurement showed a Vmean increase >100% (Fig. 2; D).
During all TCD measurements the systolic BP was signiﬁcantly
lower after declamping compared to the pre-clamping systolic BP,UMCU N ¼ 112 St. Antonius
Hospital N ¼ 72
P-value
Mean (SD) Mean (SD)
69.1 (9.8) 68.4 (10.1) 0.68
88 (79%) 53 (74%) 0.438
26 (23%) 10 (17%) 0.330
85 (76%) 50 (69%) 0.334
102 (91%) 62 (86%) 0.436
36 (32%) 14 (20%) 0.091
43 (38%) 18 (25%) 0.077
85 (76%) 39 (54%) 0.005
47 (42%) 36 (50%) 0.285
97 (87%) 62 (86%) 0.924
106 (95%) 68 (94%) 0.901
6 (5%) 4 (5%)
15 (13%) 12 (17%)
12 (11%) 5 (7%) 0.257
18 (16%) 12 (17%)
61 (55%) 33 (46%)
10 (%) 6 (14%)
11 (10%) 22 (31%) <0.001
15 (13%) 19 (26%) 0.027
5 (5%) 5 (7%) 0.469
Figure 2. Flowchart. Intra-operative TCD: TCD increase 3 min after declamping as compared to the pre-clamping values. Postoperative TCD: TCD increase on the recovery room in
the ﬁrst 2 h postoperatively compared to the preoperative values. NT: Normotensive. PH: Postoperative hypertension. CHS: Cerebral hyperperfusion syndrome.
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7.3e15). Postoperatively, the systolic BP was 4.0 mmHg lower (95%
C.I. 12.6 to 20.6) compared to the preoperative systolic BP.
Clinical outcome
Of all 184 patients, one (0.5%) patient had an intra-operative
stroke. Postoperatively, 34 patients (19%) developed PH and 10
patients (5%) suffered from CHS. All 10 patients with CHS had
hypertension during the postoperative phase. Nine fully recovered,
but one patient refused further treatment and died because of
intracranial haemorrhage. The overall 30-day rate of death/stroke
was 1%.
TCD measurements and clinical outcome
Of 16 patients with an intra-operative increase of Vmean >100%
(Fig. 2; B), nine developed PH and, of these, two patients developed
CHS. On the other hand, in 168 patients who had an intra-operative
increase less than 100% (Fig. 2; C), 25 patients developed PH and
eight of them suffered from CHS. This results in a PPV of 56% (9/16)
and a NPV of 85% (143/166) in the prediction of PH and a PPV of 13%
(2/16) and NPV of 95% (160/168) in the prediction of CHS (Tables 2
and 3).
With respect to the postoperative TCD measurements 17 of the
22 patients with a doubling of postoperative Vmean (Fig. 2; D and F)
developed PH and in nine of them CHS occurred. In the subgroup of
162 patients with postoperative increase of less than 100% (Fig. 2; E
and G), 17 patients developed PH and one patient CHS. This results
in a PPV of 77% (17/22) and a NPV of 90% (145/162) for PH and a PPV
41% (9/22) and a NPV of 99% (161/162) for the development of CHS
(Tables 2 and 3).
Of all 31 patients, who had an intra-operative and/or post-
operative Vmean increase of more than 100% (Fig. 2; B and F), 20
developed PH and nine CHS. Only one patient with CHS did not
have postoperative Vmean doubling. Of the 153 patients without an
increase >100% at any time point (Fig. 2; G), 14 patients developed
PH and one patient developed CHS. This results in a PPV of 65% (20/
31) and NPV of 91% (139/153) for the prediction of postoperative
hypertension and a PPV of 29% (9/31) and NPV of 99% (152/153) for
the development of CHS.
CHS versus non-CHS
The median (interquartile range) intra-operative Vmean increase
was 10% (0e31) in the non-CHS group (n ¼ 174) and 23% (5e85) inCHS patients (n ¼ 10; p ¼ 0.122). The differences in median post-
operative Vmean increase was 18% (1e47) in the non-CHS and 107%
(99e115) in the CHS group respectively (p < 0.005) (Fig. 3).
PH occurred in all 10 patients who developed CHS (100%) and in
only 24 patients out of 174 (14%) in the non-CHS group (p < 0.005).
There was no signiﬁcant difference in intra-operative BP
changes between the CHS and non-CHS group neither during the
intra-operative measurements (p ¼ 0.234) nor during the post-
operative measurements (p ¼ 0.463).
Discussion
An increase in Vmean measured postoperatively predicts the
development of CHS better than the commonly used increase in
Vmean measured 3min after declamping versus pre-clamping value.
The PPV of the postoperative measurement in the prediction of CHS
is more than three times higher than of the intra-operative
measurement (41% and 13%, respectively). Thus, for 28% of the
patients who developed CHS in our cohort, this complicationwould
have been predicted in an early stage if a postoperative TCD
measurement had been performed. Moreover, the absence of
doubling of the Vmean at the postoperative measurement excluded
the development of CHS almost completely. Therefore, with post-
operative measurement fewer patients will be treated unneces-
sarily by strict intravenous anti-hypertensive medication.
The association between changes in cerebral artery ﬂow after
CEA and the development of CHS has been extensively described.23
In 1988 Piepgras et al. showed that doubling of the CBF measured
by intra-carotid injection of xenon-133, was associated with the
occurrence of intra-cerebral haemorrhage.14 Nowadays, TCD, which
is relatively inexpensive and does not require radiation exposure is
widely applied for monitoring in CEA.
A critical issue is to what extent blood velocity reﬂects on actual
volume ﬂow. In the unlikely case that blood ﬂow is not laminar, the
blood velocity changes out of proportionwith volume ﬂow. Second,
changes in velocity are parallel with volume ﬂow only when both
the angle of insonation and the diameter of the vessel remain
constant. The large cerebral arteries are conductance rather than
resistance vessels and changes in systemic arterial blood pressure
within the physiological range appear to have a negligible effect on
the diameter of the insonated artery.24,25 Third, validation studies
found that changes in mean middle cerebral artery blood velocity
follow cerebral 133Xe clearance.26,27 Technical limitations of TCD
include the lack of sufﬁcient bone window in 10e15% of patients.
Furthermore, TCD monitoring, like many other diagnostic tech-
niques, is operator-dependent and requires training and experience
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Figure 3. Vmean increase for CHS and non-CHS patients. Intra- and postoperative Vmean
increase in patients who developed CHS (n ¼ 10) and patients who did not (n ¼ 174).
Values are median with interquartile range.
Table 2
Predictive values of TCD measurements for the occurrence of CHS at different
timeframes (capitals refer to Fig. 2).
CHSþ CHS PPV
(%)
NPV
(%)
Combined data
Intra-operative increase
>100% (B) 2 (1%) 14 (8%) 13 95
<100% (C) 8 (5%) 160 (86%)
Post-operative increase
>100% (D þ F) 9 (5%) 13 (7%) 41 99
<100% (E þ G) 1 (1%) 161 (87%)
Intra-operative increase Post-operative
increase
>100% >100% (D) 2 (1%) 5 (3%) 29 95
>100% <100% (E) 0 (0%) 9 (5%) 0 94
<100% >100% (F) 7 (4%) 8 (4%) 47 98
<100% <100% (G) 1 (1%) 152 (82%) 1 71
Total (%) 10 (6%) 174 (94%)
St. Antonius Hospital (retrospectively included data)
Intra-operative increase
>100% (B) 2 (3%) 10 (14%) 17 95
<100% (C) 3 (4%) 57 (79%)
Post-operative increase
>100% (D þ F) 5 (7%) 8 (11%) 38 100
<100% (E þ G) 0 59 (82%)
Intra-operative increase Post-operative
increase
>100% >100% (D) 2 (3%) 4 (6%) 33 95
>100% <100% (E) 0 6 (8%) 0 92
<100% >100% (F) 3 (4%) 4 (6%) 43 97
<100% <100% (G) 0 53 (73%) 0 74
Total (%) 5 (7%) 67 (93%)
UMCU (prospectively included data)
Intra-operative increase
>100% (B) 0 4 (4%) 0 95
<100% (C) 5 (4%) 103 (92%)
Post-operative increase
>100% (D þ F) 4 (4%) 5 (4%) 44 99
<100% (E þ G) 1 (1%) 102 (91%)
Intra-operative increase Post-operative
increase
>100% >100% (D) 0 1 (1%) 0 95
>100% <100% (E) 0 3 (2%) 0 95
<100% >100% (F) 4 (4%) 4 (4%) 50 99
<100% <100% (G) 1 (1%) 99 (88%) 1 67
Total (%) 5 (4%) 107 (96%)
CHSþ: number of patients who developed CHS (%). CHS: number of patients who
did not develop CHS (%). PPV: positive predictive value (%). NPV: negative predictive
value (%).
Table 3
Predictive values of TCD measurements for the occurrence of post-operative
hypertension (PH) at different timeframes (capitals refer to Fig. 2).
PHþ PH PPV
(%)
NPV
(%)
Intra-operative increase
>100% (B) 9 (5%) 7 (4%) 56 85
<100% (C) 25 (13%) 143 (78%)
Post-operative increase
>100% (D þ F) 17 (9%) 5 (3%) 77 90
<100% (E þ G) 17 (9%) 145 (79%)
Intra-operative
increase
Post-operative
increase
>100% >100% (D) 6 (3%) 1 (1%) 86 84
>100% <100% (E) 3 (2%) 6 (3%) 33 82
<100% >100% (F) 11 (6%) 4 (2%) 73 86
<100% <100% (G) 14 (7%) 139 (76%) 9 35
Total (%) 34 (18%) 150 (82%)
PHþ: number of patients who developed PH (%). PH: number of patients who did
not develop PH (%). PPV: positive predictive value (%). NPV: negative predictive
value (%).
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measurements were performed by experienced personnel, the
reproducibility of TCD measurement is high. According to litera-
ture, TCD determination of Vmean are reproducible with a difference
of less than 3% with R ¼ 0.95.
Ogasawara et al. showed that the accuracy of intra-operative
TCD monitoring is less reliable in predicting CHS than TCD at the
end of the procedure.20 However, they deﬁned postoperative TCD
as ‘at the end of the procedure at the operating room’, while the
patient was still inﬂuenced by anaesthetic medication. As anaes-
thetics may reduce cerebral blood ﬂow, these values could not be
reliably comparedwith preoperative TCD values. As far as we know,
analysis or studies comparing the accuracy of postoperatively with
intra-operatively measured TCD values in the prediction of CHS
have never been performed. Therefore, besides determination of
the cerebrovascular reserve capacity with 123I-IMP SPECT13 or
TCD28 after acetazolamide administration, preoperative selection of
patients at risk to develop CHS is not yet possible, sincewell-knownpatient factors supposedly predisposing for CHS have not been
clariﬁed, or have been analysed for a single risk factor only.8
In our study, only 10 of patients developed CHS. The low inci-
dence of CHS hampers the interpretation of our results. This small
number did not allow multivariate statistical analysis (logistic
regression). However, the incidence in our group (5%) of patients is
relatively high compared to other series. This might be explained by
the fact that in our referral hospitals a selected group of patients
with relatively severe haemodynamic compromise are treated. To
determine the inﬂuence of the retrospective inclusion of the St.
Antonius Hospital patient cohort, analyses on outcome were
stratiﬁed according to hospital. The ﬁrst variable that signiﬁcantly
differed between both hospitals was alcohol use, which we believe
is coincidence and does not affect the risk for CHS. Furthermore,
postoperative hypertension and the use of an intra-operative shunt
was more frequently present in the St. Antonius patients. This can
be explained by the fact that postoperative TCD was preferentially
performed in patients with PH or an intra-operative Vmean increase
of >100%. Also the use of intra-operative shunting was believed to
potentially increase the risk of CHS and, as a consequence, this was
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and UMCU (31% vs. 10%, p < 0.001, respectively, Table 1).
As patients were followed up by a postoperative TCD
measurement, but being treated (for BP control) based on the intra-
operative TCD measurement, this approach might have led to an
underestimation of the predictive value of intra-operative
measurements in the UMCU.
Nevertheless, the difference in incidence of CHS between the
prospectively and retrospectively included datawas small and non-
signiﬁcant (5% vs. 7%, respectively; Table 1) and the predictive
values were almost identical in both hospitals. Importantly, in both
hospitals the majority of CHS patients being identiﬁed by post-
operative TCD but being missed by intra-operative TCD were
signiﬁcant in both hospitals (Table 2). Thus, the assumption that
postoperative measurement improves identiﬁcation of patients at
risk for CHS was conﬁrmed in each hospital separately in equal
measures. These ﬁndings further underline the lack of signiﬁcant
preoperative and intra-operative prediction models for CHS
development by technical aspects of the procedure.
We assume that the changes in Vmean could not be explained by
the differences in BP among the several TCD measurements, since
the changes in BP were inversely correlated to the changes in Vmean
(increase) for the intra-operative measurements and no signiﬁcant
change in MAP was found between the pre- and postoperative TCD
measurements.
In conclusion, besides the commonly used intra-operative TCD
monitoring, additional TCD measurement in the early post-
operative phase is useful to predict CHS in patients who underwent
CEA under general anaesthesia. However, this observation needs to
be validated for patients undergoing CEA under local anaesthesia.
Furthermore, most patients who develop CHS do so following prior
PH development. Therefore, anti-hypertensive treatment for all
patients having PH should be administered appropriately since
they are at risk to develop CHS subsequently.
By measuring Vmean in the postoperative instead of only in the
intra-operative phase, both the positive and negative predictive
values of TCD for development of CHS after CEA can be improved.
Therefore, we recommend a baseline measurement before the
administration of anaesthetics and a postoperative measurement
within 2 h after surgery.Acknowledgements
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